220 related articles for article (PubMed ID: 6318628)
1. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.
Collen MJ; Howard JM; McArthur KE; Raufman JP; Cornelius MJ; Ciarleglio CA; Gardner JD; Jensen RT
Ann Intern Med; 1984 Jan; 100(1):52-8. PubMed ID: 6318628
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
[TBL] [Abstract][Full Text] [Related]
3. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
4. Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome.
Saeed ZA; Norton JA; Frank WO; Young MD; Maton PN; Gardner JD; Jensen RT
Gastroenterology; 1989 Jun; 96(6):1393-402. PubMed ID: 2565842
[TBL] [Abstract][Full Text] [Related]
5. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
6. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
7. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Vinayek R; Hahne WF; Euler AR; Norton JA; Jensen RT
Dig Dis Sci; 1993 Oct; 38(10):1857-65. PubMed ID: 8104773
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Maton PN; Gardner JD; Jensen RT
Gastroenterol Clin North Am; 1989 Dec; 18(4):847-63. PubMed ID: 2575602
[TBL] [Abstract][Full Text] [Related]
9. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill.
More DG; Raper RF; Munro IA; Watson CJ; Boutagy JS; Shenfield GM
Surgery; 1985 Feb; 97(2):215-24. PubMed ID: 3881838
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine.
Strum WB
JAMA; 1983 Oct; 250(14):1894-6. PubMed ID: 6312110
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study.
Richardson CT; Peters MN; Feldman M; McClelland RN; Walsh JH; Cooper KA; Willeford G; Dickerman RM; Fordtran JS
Gastroenterology; 1985 Aug; 89(2):357-67. PubMed ID: 2861140
[TBL] [Abstract][Full Text] [Related]
12. Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome.
Bardram L; Stadil F
Scand J Gastroenterol Suppl; 1989; 166():95-100; discussion 111-3. PubMed ID: 2574912
[TBL] [Abstract][Full Text] [Related]
13. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
[TBL] [Abstract][Full Text] [Related]
14. Role of acid suppressants in patients with Zollinger-Ellison syndrome.
Maton PN
Aliment Pharmacol Ther; 1991; 5 Suppl 1():25-35. PubMed ID: 1679671
[TBL] [Abstract][Full Text] [Related]
15. Development of cimetidine resistance in the Zollinger-Ellison syndrome.
Andersen BN; Larsen NE; Rune SJ; Worning H
Gut; 1985 Nov; 26(11):1263-5. PubMed ID: 4065699
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.
Vallot T; Mignon M; Mazure R; Bonfils S
Dig Dis Sci; 1983 Jul; 28(7):577-84. PubMed ID: 6305607
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP
Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine hydrochloride.
Gaginella TS; Bauman JH
Drug Intell Clin Pharm; 1983 Dec; 17(12):873-85. PubMed ID: 6317325
[TBL] [Abstract][Full Text] [Related]
19. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T
Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
[TBL] [Abstract][Full Text] [Related]
20. Actions of cimetidine and ranitidine at some cholinergic sites: implications in toxicology and anesthesia.
Gwee MC; Cheah LS
Life Sci; 1986 Aug; 39(5):383-8. PubMed ID: 2874464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
